PHAD?-504
Monophosphoryl Lipid A-504
PHAD?-504 was designed as a synthetic structural analog of detoxified MPLA derived from E. coli lipopolysaccharide (LPS). It is structurally similar to PHAD?, differing only in the length of a single fatty acid chain. As expected, the activity of PHAD?-504 is quite similar to that of PHAD?, making the two products interchangeable as adjuvants in vaccine or immunotherapy formulations.
 
                                 購物車為空,快去購物吧!
購物車為空,快去購物吧!
                                     
                         4000-520-616
4000-520-616

 
                                
 咨詢顧問
咨詢顧問



 
                                        
                                    